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Mismatch Negativity is a functional index of the 
supratemporal auditory cortex. Aim: The aim of the present 
study on Mismatch Negativity (MMN) in multiple sclerosis (MS) 
patients was to evaluate if the MMN can be correlated with 
cognitive deficits assessed by the Paced Auditory Addition 
Task - PASAT. Method: a clinical study in forty females and 
20 males separated in two groups: control individuals and 
those with a definite diagnosis of MS underwent a duration 
and frequncy MMN. The MMN latencies and negative 
amplitudes obtained from the MS group were compared to 
the ones from the control group. The scores from the Paced 
Auditory Addition Task were correlated either with the 
presence or the absence of MMN. Results: MMN was found 
in 60% of the individuals with multiple sclerosis within the 
auditory stimulation protocol with varied durations, and in 
45 % within the auditory stimulation protocol with frequency 
variations. There were no statistically significant differences 
in latencies and amplitudes when compared to controls. We 
found a statistically significant correlation for the lack of 
MMN wave together with cognitive disorder asserted by the 
PASAT. Conclusions: The MMN correlated to the cognitive 
deficit assessed by the PASAT.
Keywords: attention, auditory cortex, multiple sclerosis, 
evoked potentials.
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INTRODUCTION
Evoked Potentials (EPs) are brain electrical ma-
nifestations in response to external stimuli. The clinical 
usefulness of these potentials is based on the capacity to: 
show abnormal function of the sensorial system; reveal 
dysfunctions of the sensorial system in demyelination 
diseases; aid in the definition of disease anatomical distri-
bution and objectively monitor changes in the clinical con-
ditions of patients1. EPs are small characteristic variations 
in the electroencephalogram, related to sensorial, motor 
or cognitive stimuli, thus becoming a neurophysiological 
indicator1,2.
EPs may be classified as sensorial or exogenous 
and endogenous or cognitive1,2. Exogenous potentials are 
determined by the physical and temporal characteristics of 
the stimuli and are directly related to them. The endoge-
nous depend on the individual, the task performed, and 
the stimuli content and are correlated to brain processing 
activities3.
Recent progress in brain functioning and the deve-
lopment of anatomical brain activity localization in human 
beings who perform specific tasks, has allowed for these 
new clinical applications for brain EPs4.
One of the EPs components, called Mismatch Ne-
gativity (MMN)5 allowed the development of objective 
procedures for physiological assessments of great interest 
to neurology, psychiatry and otorhinolaryngology4.
MMN is one endogenous component of EPs, obtai-
ned when we present to a subject or patient one block of 
hundreds of identical stimuli (patterns) which are randomly 
replaced by acoustically different stimuli (deviants). These 
stimuli, patterns and deviants should bear mild differences 
in acoustic characteristics, such as: duration, frequency, 
intensity, spatial location or, still, by the use of phonemes 
or music notes. In order to obtain MMN, it is necessary that 
acoustic stimuli attention be distracted by a visual task.
We obtain the MMN subtracting responses elicited 
by the standard stimuli of deviant stimuli responses, re-
cording a negative wave that, depending on the deviant 
stimuli amplitude appears between 100 and 250 millise-
conds (ms) after the stimuli onset. 
The negativity is generated by changes in the dis-
crimination process that occur in the auditory cortex and 
reflects the auditory sensorial memory. It may be used as 
an indicator of the cortex functional status, of perceptive 
sensorial capacity, as an index of the hearing processing 
and the neural plasticity of the auditory system6.
MMN is a reproducible potential7, triggered when 
there is a difference between standard stimuli and the fre-
quency deviants in duration, in intensity, in spatial location, 
in phonetic characteristics, rhythmic characteristics and 
temporal pattern. These differences among stimuli should 
not be large8, and it may alter both the latency and the 
amplitude of stimuli duration11 and intensity12 may interfere 
in the establishment of neural representation, and should 
be properly controlled.
Multiple Sclerosis (MS) is an immune-mediated, 
demyelinating, inflammatory disease that affects the ner-
vous system. It is mainly found in young female adults, 
presenting periods of specific symptoms worsening and 
remission. Alterations are frequent in the optic nerve, 
the spinal chord, and the brain stem and periventricular 
regions. Diagnosis is clinical, based on spatial and tem-
poral lesion spread to the Central Nervous System. MS 
diagnosis is clinically defined by the Poser criteria - the 
occurrence of at least two spells and clinical evidence of 
two separate lesions, or two spells and clinical evidence 
of one lesion and paraclinical evidence of another. These 
two spells should involve different parts of the Central 
Nervous System, being one month apart, and each one 
lasting for at least 24 hours13. Complementary tests that 
support clinical diagnosis are: MRI, CSF exam to search for 
oligoclonal bands, IgG formation rate in the CSF; visual, 
somatosensorial and auditory evoked potentials.
MS patient assessment by means of long latency 
auditory evoked potentials14 has shown alterations in 
wave latency and shape15,16, as its correlation with altered 
neuropsychological tests17.
Cognitive alterations may affect MS patients. Neu-
ropsychological studies show that cognitive dysfunction 
happens in 54 to 65%18 of patients and these may alter 
memory, attention, verbal fluency, task performance and 
visual perception19. The Compound Functional Measure 
for Multiple Sclerosis (MSFC)20 was developed based on 
psychometric tests in patients with MS, bearing the follo-
wing tests: 25 feet timed walk; 9 pins in the hole test, and 
the Paced Auditory Addition Test - PASAT21.
Neurological tests are very useful in assessing cog-
nitive function, among them, the PASAT21 is a sensitive 
and practical test used to assess MS cognitive involvement. 
The PASAT scores of each MS patient are compared to a 
control group that matches the former in age, educational 
level and socio-economical status22.
OBJECTIVES
The goals of the present study are: to use MMN in 
clinically diagnosed MS patients and investigate whether 
or not MMN can be used as a functional index of the 
supratemporal auditory cortex and analyze if MMN alte-
rations correlate to the cognitive impairment assessed by 
the PASAT test.
MATERIALS AND METHODS
The Research Ethics Committee of the Federal 
University of São Paulo/São Paulo Hospital analysed and 
approved the project, protocol #º 0638/03.
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40 females and 20 males participated on this study. 
They were further divided in 2 groups: Control group and 
MS group, who read and signed an informed consent 
approved by the Research Ethics Committee.
For the MS group, we selected both men and wo-
men: 30 women with ages varying between 26 and 58 
years, 43.1 years of average and 10 men, between 29 and 
57 years - 39.4 of mean age. All the patients in this latter 
group had Clinically Established diagnosis of Multiple 
Sclerosis, according to Poser criteria, and did not have 
signs of MS worsening at the time of the tests and the 
MMN recording, or visual disorders that could interfere 
in the visual distraction task. All patients underwent an 
otorhinolaryngology exam and tonal audiometry in order 
to assess tonal thresholds at the frequencies of 500, 1,000 
and 2,000 Hz.
To make up the control group, we selected indivi-
duals of both genders, with ages matching those from the 
MS group: 10 women with ages varying between 27 and 
50 years, mean age of 40.1 years; and 10 men, between 
25 and 55 years, mean age of 37.9, without prior history 
of neurologic or otorhinolaryngological disorders. They 
all underwent otorhinolaryngological exam, not showing 
alterations at the otoscopy and tonal audiometry thresholds 
below or equal to 25 dB HL at the frequencies of 500, 
1,000 and 2,000 Hz. None of them used drugs that could 
affect the Central Nervous System.
For MMN recording, we used a group of stimuli 
with duration variation and another group with frequency 
variation, presented by means of TDH-39 supra-aural 
phones.
In the stimuli group that varied the duration, we 
used tones at a 55 dB HL intensity, in both ears, with a 
total of 1,000 tones, 80% of standard stimuli and 20% de-
viant stimuli, at a frequency of 750 Hz, the standard stimuli 
lasted for 75ms and the deviants lasted 25ms. Deviant to-
nes were randomly assigned by the computer among the 
standard ones. As stimuli rate, we used 1.1 stimulus per 
second (/s). The standard tones used had linear ascending 
and descending times, plateauing in 55ms. Deviant tones 
had 5ms of linear ascending and descending times, with 
a 15ms plateau.
In the frequency variation stimulus group, we used 
tones at 55 dB HL, on both ears, at a total of 1,000 tones, 
80% of standard stimuli and 20% deviant stimuli, lasting 
for 50ms; standard stimuli at a frequency of 1,000 Hz and 
deviant stimuli at a frequency of 1,500 Hz. Deviant tones 
were randomly assigned by the computer among the 
standard tones. As stimulus rate, we used 1.1 stimulus /s. 
Both standard and deviant tones had 10ms of ascending 
and descending linear time, with 30ms plateau, both tones 
with linear ramp.
Recordings were carried out in a sound-treated 
environment, with the subjects comfortably laying on 
their backs, with a 45º upward head tilt and the head was 
supported by a pillow in order to relax neck muscles, and 
as a distraction visual task we showed them a subtitled 
movie, without sound, on a video screen. All recordings 
were carried out at the same time, in the morning. 
For this investigation we used a two-channel 
Biologic® evoked potentials equipment, and the recording 
was carried out by silver electrodes placed on the midline 
of the forehead and central, in the Fz and Cz leads, the 
ear lobes were used as reference points, and a lead on 
the nose tip was used as ground wire, they were attached 
by means of an adhesive tape, after skin raking and elec-
trolytic paste was used on the skin. Electrodes impedances 
were kept bellow 5 K ohms.
We used 512ms as analysis time, high pass filters 
at 0.1 Hz and low pass at 100 Hz.
Signal acquisition onset was adjusted with the exact 
onset of hearing stimulation.
MMN was considered as maximum negative peak 
between 100 and 250ms, in Fz e Cz, obtained by the 
difference curve, subtracting the standard stimulus res-
ponse curve from the deviant stimuli response curves. We 
analyzed difference wave shapes, latencies and negative 
amplitude measured in ms e µV. We also analyzed MMN 
presence or absence after wave subtraction.
The group with MS underwent MSFC test, and the 
Paced Auditory Addition Test - PASAT was used as a 
cognitive impairment index. PASAT was carried out in the 
version with 3 seconds inter-stimuli intervals which were 
numbered from 1 to 9 in pseudo-randomized sequence, 
stored in a Compact Disk. The subject’s task was to add 
up the numbers two by two and provide the result, as they 
heard the next number, the third, add it to the previous 
one, according to the Brazilian Portuguese version adapted 
by Haase et al.14. The PASAT raw score was defined by 
the number of correct answers for the summations.
Disorders seen at the PASAT were defined as a raw 
score equal to or below 27. Above this value. The PASAT 
was considered normal.
MMN presence or absence, in both auditory stimula-
tion protocols, was compared to the presence of cognitive 
impairment assessed by the PASAT.
The age means were compared by the Variance 
Analysis Test (ANOVA) between genders and MS and 
control groups.
The ANOVA test was applied in order to compare 
MMN negative amplitude and latencies between the control 
and MS groups, between the genders and the recording 
leads (Fz and Cz).
We used the Fischer test in order to compare MMN 
presence or absence with cognitive impairment assessed 
by PASAT.
For both tests we used 5% as significance level.
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RESULTS
Table 1 shows the statistical analysis and compari-
sons of age means between genders and the groups.
MMN was recorded in 60% of the patients in the 
duration variation protocol, and in 45% in the group with 
frequency variation protocol in the group of patients 
Table 1. Statistical analysis and comparison of the mean ages and 
standard deviations between genders and the groups.
Group Statistics Females Males
C
Mean 40,10 37,90
Standard Deviation 8,319 10,826
n 10 10
MS
Mean 43,10 39,40
Standard Deviation 8,130 10,298
n 30 10
C - Control Group
MS - Group with Multiple Sclerosis
ANOVA
Effect F (p) Significance
Group 0,3908
Gender 0,2617
Group x Gender 0,7742
Table 2. MMN latency standard deviation and mean in the hearing 
stimulation protocol with duration variation in males and females, in 
the Cz and Fz leads, in both controls and MS patients..
Females Males
Group Statistics Cz Fz Cz Fz
C
Mean 194,60 192,40 180,20 178,80
Standard Deviation 30,51 27,79 24,63 25,13
n 10 10 10 10
MS
Mean 180,44 182,11 183,20 172,40
Standard Deviation 26,59 29,64 41,00 44,05
n 18 18 5 6
C - Control Group
MS - Group with Multiple Sclerosis
Table 3. MMN negative amplitude mean and standard deviation in 
the hearing stimulation protocol with duration variation for males and 
females, in the Cz and Fz leads in both Control and MS groups.
Females Males
Group Statistics Cz Fz Cz Fz
C
Mean -3,22 -3,66 -3,23 -3,48
Standard Deviation 1,51 1,70 0,83 1,33
n 10 10 10 10
MS
Mean -2,76 -2,82 -2,87 -2,81
Standard Deviation 1,34 0,93 0,90 0,85
n 18 18 5 6
C - Control Group
MS - Group with Multiple Sclerosis
Table 4. MMN latency mean and standard deviation in the hearing 
stimulation protocol with frequency variation for males and females, 
in the Cz and Fz leads in both Control and MS groups.
Females Males
Group Statistics Cz Fz Cz Fz
C
Mean 148,20 147,60 158,40 160,80
Standard Deviation 41,58 42,27 37,65 36,83
n 10 10 10 10
MS
Mean 153,23 152,62 181,20 180,00
Standard Deviation 43,35 41,69 31,13 34,09
n 13 13 5 5
C - Control Group
EM - Multiple Sclerosis Group
with MS. The latter did not show statistically significant 
differences in MMN negative amplitude and latencies 
between the MS and control groups in both genders and 
leads (Tables 2 to 5).
Tables 6 and 7 show the statistical analysis and com-
parisons between MMN presence or absence and cognitive 
Table 5. MMN negative amplitude mean and standard deviation in the 
hearing stimulation protocol with frequency variation for males and 
females, in the Cz and Fz leads in both Control and MS groups.
Females Males
Group Statistics Cz Fz Cz Fz
C
Mean -1,77 -2,32 -2,62 -1,89
Standard Deviation 2,13 1,02 1,37 2,15
n 10 10 10 10
MS
Mean -2,29 -2,18 -2,70 -2,15
Standard Deviation 0,97 1,28 1,51 1,86
n 13 13 5 5
C - Control Group
EM - Multiple Sclerosis Group
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Table 7. Statistical analysis and comparison between MMN presence or 
absence in the hearing stimulation protocol with frequency variation and 
the presence of impairment, assessed by PASAT in the MS group.
Duration Test
Absent Present Total Fisher
PASAT n % n % n % (p)
Without impair-
ment 
5 21,73 12 66,6 17 42,5
With impairment 17 73,91 6 33,3 23 57,5 0,010*
Total 23 100,0 18 100,0 40 100,0
Figure 1. Exogenous long latency hearing evoked potentials recording 
in the duration variation protocol in the control group. F - recording in 
response to frequent stimulus I - recording in response to infrequent 
stimuli
Figure 2. Mismatch Negativity shown by the difference wave obtained 
with frequent and infrequent stimuli in the hearing stimulation protocol 
with duration variation in the control group.
Figure 3. Exogenous long latency hearing evoked potentials with du-
ration variation in the MS group. F - Frequent stimuli response record 
I - infrequent stimuli response record
Table 6. Statistical analysis and comparison between MMN presence or 
absense in the hearing stimulation protocol with duration variation and 
the presence of impairment, assessed by PASAT in the MS group.
Duration Test
Absent Present Total Fisher
PASAT n % n % n % (p)
Without impair-
ment 
2 12,5 15 62,5 17 42,5
With impairment 14 87,5  9 37,5 23 57,5 0,003*
Total 16 100,0 24 100,0 40 100,0
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impairment assessed by PASAT in the MS group.
Figures 1 to 5 show wave potential examples of 
long latency and MMN in the control and multiple scle-
rosis groups.
DISCUSSION
MMN, described by Näätänen et al.5, is a potential 
elicited by low probability hearing stimuli that represent 
a physical change in relation to a repetitive standard sti-
mulation. It is automatically generated, regardless of the 
subject’s attention, whenever an afferent stimulus does 
not coincide with the sensorial representation of the 
physical characteristics of the repetitive stimulation. The 
MMN generating process is of pre-attention characteristic, 
with neuro-electrical contributions of the frontal cortex, 
which participates in attention voluntary and involuntary 
mechanisms.
The major advantage brought about by the evoked 
potentials, when compared to other neurocognitive me-
thods is that the former lets us record neuronal activities 
associated to brain processing, making it possible to assess 
cerebral areas that are activated during the processing of 
cognitive tasks. With the MMN it is also possible to esti-
mate echoic memory duration; many studies submit the 
endogenous origin of such potential. 
The goal of clinical studies that use event-related 
evoked potentials is to show either the presence or ab-
sence of responses that are different from those of normal 
subjects.
In order for one individual to recognize a complex 
acoustic response as similar to one previously known, the 
sensorial representation of such stimulus must activate 
afferent currents6. When the acoustic difference between 
standard tones and their deviant counterparts is small, 
it becomes easier for the subject to ignore the hearing 
stimuli. Näätänen5 considers that deviations of up to 10% 
are efficient in producing a pure MMN. Lang et al.8 report 
that, with a great difference between stimuli, the neurons 
activated in the auditory cortex by deviant stimuli are not 
the same that are activated by the standard stimuli, and they 
recommend we should avoid large differences between 
stimuli. In the present study, the protocol with duration 
variation in stimuli caused proper stimuli difference in 
order to elicit MMN. Näätänen5 reports that when this di-
fference exceeds the critical threshold, a P3a component 
may overlap the response, thus compromising MMN Recor-
ding. Sams et al.9 described a latency reduction and MMN 
amplitude increase with the increase in stimuli frequency 
difference. Böttcher-Gandor and Ullsperger10 used 1000 
Hz Standard tones and 1500 Hz deviant tones, identifying 
MMN with its characteristic traces and amplitudes. Our 
stimuli protocol with frequency variation using the same 
frequencies was able to elicit MMN without P300 or its 
P3a subcomponent. 
Figure 5. Exogenous long latency hearing evoked potentials recording 
and the difference wave obtained from frequent and infrequent stimuli, 
with no Mismatch Negativity in the duration variation protocol in the 
Multiple Sclerosis group. 
Figure 4. Mismatch Negativity shown by the difference wave obtained 
with frequent and infrequent stimuli in the hearing stimulation protocol 
with duration variation in the multiple sclerosis group.
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The tone duration to be used in blocks in order to 
elicit MMN must be enough to establish the Standard sti-
muli neuronal representation. Paavilainen et al.11 reported 
that the stimuli duration may be small, at 50ms or less if 
the intension is to register an MMN with frequency varia-
tion. They also recommend that the minimum standard 
and deviant stimulus duration were of 75ms and 25ms 
respectively, in the duration variation protocol, and 30ms 
in the frequency variation protocol. These stimuli elicited 
MMN in both groups.
According to Schröger12, the stimuli intensity influen-
ce on the MMN creation, elicited by other alterations such 
as frequency or duration is yet to be determined. MMN can 
be recorded even at low stimuli intensities, when both the 
Standard and deviant stimuli can be perceived at 30 dB 
SPL. Escera and Grau7 proved MMN reproducibility using 
85 dB SPL of stimulus intensity with supra-aural phones. 
In the present study, we chose to use stimuli both in the 
frequency variation protocol and the duration variation, 
at 55 dB HL, making it possible to Record the subjects in 
the control group and in the MS group. 
Grau et al.7, using Standard stimuli of 75ms in dura-
tion (likelihood =0.83) and 25ms deviant stimuli (likelihood 
= 0.17), with 700 Hz and 85 dB SPL of intensity, with 
binaural presentation and inter-stimuli intervals of 0.4 s 
and 4.0s in different stimulation blocks, observed the EPs 
in response to Standard stimuli with a typical morphology 
characterized by P1, N1 and P2 waves. These exogenous 
potentials are sensitive to the stimuli physical characte-
ristics. MMN was seen in response to the two stimulation 
blocks, thus characterizing the endogenous nature of such 
potential. In the present study, the duration variation pro-
tocol, using 75ms duration standard stimuli (likelihood = 
0.80) and 25ms deviant stimuli (likelihood = 0.20), at 750 
Hz and 55 dB HL of intensity, with binaural presentation 
and Constant maintenance of inter-stimuli intervals were 
able to elicit the P1, N1 and P2 exogenous potentials and 
the MMN in all control group subjects. 
The MMN was present in 60% of the MS individuals 
group in the hearing stimulation protocol with duration 
variation and in 45% in the hearing stimulation protocol 
with frequency variation. In these recordings there was no 
statistically significant difference in MMN negative amplitu-
de and latency when compared to the control group. Such 
findings confirm the echoic memory preservation in this 
group of MS individuals in whom the MMN was recorded, 
since they did not show statistically significant differences 
in negative amplitude and latencies when compared to 
the control group. 
In MS, the electrophysiological evaluation of CNS 
functions carried out by visual evoked potentials, short 
latency auditory and somatosensitive potentials are well 
established. However, event-related EPs have been broadly 
studied because of their correlation with cognitive aspects, 
indicating integrity of the neurophysiological pathways, 
related to exogenous sensorial information. Endogenous 
evoked potentials, called event-related, are correlated to 
the cognitive function. The alterations found in these po-
tentials are defined by wave extension or the lack of the 
characteristic peak formation. 
The alterations found in the present study with MS 
patients were the lack of responses in 40% of the indivi-
duals in the hearing stimulation protocol with duration va-
riation and in 55% in the hearing stimulation protocol with 
frequency variation. Newton et al.14 found an incidence of 
57% of cognitive potential alterations that included delays 
in wave latencies and lack of its characteristic morpholo-
gy. Dijk et al.15 did not find differences in event-related 
evoked potentials in a group of 30 patients with MS, with 
an incidence of 15.6% of wave peak absence of all the 
potentials assessed.
Cognitive function reduction is a common manifes-
tation in MS. The most frequent are memory, attention, 
processing speed and verbal fluency alterations. There 
may also be alterations in visual acuity and language. 
Some authors suggest that the MS cognitive alterations 
patterns are similar to those found in other diseases that 
affect these subcortical structures. 
Neuropsychological tests make up the gold Stan-
dard in determining the cognitive function present in MS. 
Neuropsychologists have an array of tests to assess the 
most commonly affected functions. 
The MSFC, developed by Cutter et al.20, based on 
an analysis of psychometric tests in MS patients is made 
up of three measures: walking skills, manual dexterity 
and cognitive function evaluation - by PASAT. Haase et 
al.22 developed a Brazilian version for the MSFC, made 
up of the following tests: 25 feet timed walk, 9 pin in the 
hole test and the PASAT. These authors concluded that 
processing speed is one of the PASAT functions and it is 
affected in MS. 
The PASAT is considered a practical test, and one 
sensitive in recognizing MS cognitive impairment. The 
present study aimed at correlating MMN recording altera-
tions with cognitive function impairment in a group of MS 
patients. The PASAT score average for males was of 27.8 
and for females was of 28.43. Scores equal to or below the 
25th percentile were considered as cognitive impairment 
assessed by PASAT. Haase et al.22 defined this percentile 
for a control group with age, educational level and socio-
economical level matching those from the MS group. 
We then used this study to compare MMN presence 
or absence with PASAT-measured cognitive impairment, 
making a qualitative data analysis. We found a statistically 
significant correlation between the lack of MMN wave with 
cognitive impairment. 
Rao et al.18 assessed the cognitive function in MS 
by means of an array of neuropsychologic tests, and 
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found 25% of alterations in the attention assessment tests, 
measures by PASAT and the verbal fluency tests, without 
association with the reduction in cognitive function and 
the MS duration, depression, course of the disease or use 
of medication. In the present study, we found 57.5% of MS 
patients with PASAT alterations. Depression, MS and the 
use of medication were not considered, and none of the 
subjects were in MS exacerbation period. Giesser et al.16 
found higher N100, P200 and P300 potential latencies in the 
MS patients with dementia; and worse neuropsychologic 
test performance related to an increase in P300 latency.
Gil et al.17 tried to correlate P300 latency increase 
with alterations in the neuropsychological tests in MS 
patients, and they did not find amplitude and latency 
differences in P200, N200 and P300 potentials among the 
subgroups classified by the McAlpine criteria. In the pre-
sent study, it was possible to correlate MMN to alterations 
in a neuropsychological test. 
Newton et al.14 reported that event-related evoked 
potential generation would be, in part, dependant on white 
matter integrity, and mild degrees of cognitive dysfunction 
would not always be detected by intellectual capacity 
assessment tests, thus the possibility of objective tests, 
carried out by event-related evoked potentials become a 
useful tool in clinical practice. 
CONCLUSIONS
From this study using MMN in MS patients we may 
conclude that: when present in MS, MMN may be used 
as a supratemporal auditory cortex functional index, and 
its absence is related to cognitive impairment, found by 
the PASAT test.
Further studies are necessary in order to better 
understand MMN and its topographic distribution in the 
skull of MS patients, and thus allowing us to objectively 
assess attention and cognition, and better rehabilitate and 
follow these patients clinically. 
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